Review
Open access
Sep 2026
Antidiabetic Agents in the Management of Hepatic Fibrosis in Type 2 Diabetes Mellitus and MASLD/MASH: A Narrative Review
This article aims to review antidiabetic agents with evidence supporting hepatic fibrosis reduction, as well as those lacking such evidence.
Muhammad Ifham Hanif, Triyanta Yuli Pramana, Didik Prasetyo et al.
· Modern Medicine · 0 citations